The tariff classification of Montelukast Sodium Tablets, imported in dosage form, from India
Issued February 19, 2014 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 3004.90.9185
Headings: 3004
Product description
The subject product, Montelukast Sodium Tablets, imported in 10 mg tablet form, is a medicinal preparation containing Montelukast, a leukotriene receptor antagonist (LTRA), as the active ingredient. It is indicated for the prophylaxis and chronic treatment of asthma in adults and adolescent patients 15 years of age and older.
CBP rationale
The applicable subheading for the Montelukast Sodium Tablets in dosage form will be 3004.90.9185, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) Other: Other: Other: Medicaments primarily affecting the eyes, ears or respiratory system: Other: Other.
Full text
N249642 February 19, 2014 CLA-2-30:OT:RR:E:NC:N2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9185 Mr. Pieter H. van de Beek BluePoint Laboratories Eastgate Business Park Eastgate Road, Building 1 Little Island, Cork Ireland RE: The tariff classification of Montelukast Sodium Tablets, imported in dosage form, from India Dear Mr. van de Beek: In your letter dated January 20, 2014, you requested a tariff classification ruling. The subject product, Montelukast Sodium Tablets, imported in 10 mg tablet form, is a medicinal preparation containing Montelukast, a leukotriene receptor antagonist (LTRA), as the active ingredient. It is indicated for the prophylaxis and chronic treatment of asthma in adults and adolescent patients 15 years of age and older. The applicable subheading for the Montelukast Sodium Tablets in dosage form will be 3004.90.9185, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) Other: Other: Other: Medicaments primarily affecting the eyes, ears or respiratory system: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at (646) 733-3033. Sincerely, Gwenn Klein Kirschner Acting Director National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of ZYPRED® (0.3 % gatifloxacin and 1% prednisolone acetate ophthalmic suspension) in dosage form, from Brazil
The tariff classification of Tudorza™ Pressair™ (Aclidinium Bromide Inhalation Powder CAS-320345-99-1), imported in dosage form, from Spain.
The tariff classification of Turdorza™ Pressair™ (Aclidinium Bromide Inhalation Powder CAS-320345-99-1), imported in dosage form, from Spain.
The tariff classification of Montelukast Sodium Chewable Tablets and Montelukast Sodium Tablets, imported in dosage forms, from India
The tariff classification of Daliresp™ ( Roflumilast is INN) in measured dosage tablet form, imported in bulk from Germany
The tariff classification of Oxymetazoline Hydrochloride Concentrated Vapor Nasal Spray and Oxymetazoline Hydrochloride Moisturizing Nasal Spray in dosage form, from India
The tariff classification of Levofloxacin (CAS-100986-85-4) imported in dosage/tablet form, from India
The tariff classification of Montelukast (CAS-158966-92-8) imported in dosage/tablet form, from India
The tariff classification of Optive™ Lubricant Eye Drop
The tariff classification of Investigational New Drug VX-770 (N-(2,4-Di-tert-butyl-5-hydroxyphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide) in bulk and in dosage forms, from Portugal and the United Kingdom
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →